Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Open New India Facility

NEW YORK (GenomeWeb News) – PerkinElmer said this week that it will open a new Bio-pharma Center of Excellence in Hyderabad, India, later this year.

The center, which is scheduled to open in October, will provide PerkinElmer's clients with screening and profiling technologies, access to drug discovery tools and services and quality control applications, training facilities, and expertise.

The center will enable the company to focus on the drug discovery market in India, and it is part of PerkinElmer's plan to "substantially broaden" its presence in India in certain markets, and to expand "links with government and private research institutes," the company said.

PerkinElmer India's President, Fedja Bobanovic, said in a statement that the company is expanding in the country because it "presents compelling growth opportunities in environmental monitoring, neonatal and maternal screening, and pharmaceutical research."

In 2008 the company opened a Technology and Innovations Facility in Mumbai that focuses on environmental health sciences.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.